Feature | Karene Dumoulin, Principal Analyst, Millennium Research Group
Imaging technology and diagnostic tools for interventional cardiologists have changed dramatically over the past few years with the introduction of optical coherence tomography (OCT), improvements in intravascular ultrasound (IVUS) and pressure guide wires used in fractional flow reserve (FFR). Product innovation and integration of these technologies, as well as a growing base of clinical evidence, are transforming the way physicians diagnose, treat and follow-up patients undergoing percutaneous coronary intervention (PCI).
May 18, 2011
Feature | Dave Fornell
The biggest trend in cardiovascular ultrasound is the adoption of 3-D/4-D echo systems for better images, more data, better measurement quantification and faster workflow. Other key trends include software to speed workflow with fewer keystrokes and to enhance quantification, miniaturization, increased use of tissue strain imaging and expanded use for operating room and cath lab procedures.
May 18, 2011Feature | Mladen I. Vidovich, M.D., FACC, FSCAI
There were 15 abstracts presented describing radial access and intervention during the American College of Cardiology (ACC) and i2 Summit meeting in April in New Orleans. The abstracts focused on some of the most burning issues in current radial research.
May 18, 2011Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024
Feature | Adhir Shroff, M.D., MPH
The RIVAL trial shows there is no difference in rates of composite death, myocardial infarction, stroke or major bleeding between radial access and femoral access strategies, but radial access decreased major vascular complications.
May 18, 2011
News
May 18, 2011 - The Society for Imaging Informatics in Medicine (SIIM) announces tools and training to help medical informaticsprofessionals stay competitive in a rapidly changing environment. SIIM will provide fundamental, up-to-date education and solutions essential for imaging informatics professionals (IIPs) and their organizations at the society's 2011 annual meeting, June 2-5, in Washington, D.C./National Harbor, Md.
May 18, 2011
Feature | Dave Fornell
As medicine continues its march away from open surgical procedures to minimally invasive and transcatheter treatments, the cath lab has opened up to new treatment areas beyond the coronaries. Peripheral artery disease (PAD) in the legs has traditionally been the territory of vascular surgeons, but there has been a major transition to transcatheter PAD procedures in the past 10 years, blurring the lines between surgeons and interventionalists.
May 18, 2011Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024News
May 18, 2011 – The world’s first system to integrate the functional and anatomical modalities of fractional flow reserve (FFR) and optical coherence tomography (OCT) into one platform will be highlighted by St. Jude Medical at the Paris Course on Revascularization (EuroPCR) 2011.
May 18, 2011
News
May 18, 2011, – Lantheus Medical Imaging Inc. announced data from a Phase 2 clinical trial that demonstrated positron emission tomography (PET) myocardial perfusion imaging with flurpiridaz F 18 provided superior image quality, diagnostic certainty and diagnostic performance for detecting coronary artery disease (CAD) compared to single photon emission computed tomography (SPECT) myocardial perfusion imaging (MPI), the current standard for the non-invasive detection of CAD. The data also demonstrated a positive safety profile for PET imaging with flurpiridaz F 18.
May 18, 2011News
May 17, 2011 - Medrad Inc., a business of Bayer HealthCare, today announced it has received CE Mark for its Cotavance Paclitaxel Coated Balloon Angioplasty Catheter with Paccocathtechnology. The Cotavance catheter is used in percutaneous interventions for the treatment of peripheral arterial disease (PAD) and is approved for balloon dilation of stenotic lesions in the iliac and infrainguinal arteries while applying paclitaxel to the vessel wall to inhibit restenosis. Medrad Interventional has started selling its Cotavance catheter in countries where it has already received regulatory approval, including select European and Middle East countries. The announcement was made in conjunction with the Congress of the European Association of Percutaneous Cardiovascular Interventions (EuroPCR) in Paris.
May 18, 2011Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
News
May 18, 2011 - Jasbir Sra, M.D., and Tanvir Bajwa, M.D., are the first in Wisconsin to implant a new device in a patient’s heart that may reduce strokes in individuals suffering from atrial fibrillation, a common heart arrhythmia. This minimally invasive procedure was part of a clinical trial taking place at Aurora St. Luke’s Medical Center.
May 18, 2011
Technology
May 18, 2011 - Arstasis is pleased to announce the U.S. launch of its latest commercial product - the Axera Access Device. The Axera Device enhances insertability into the femoral artery and overall procedural usage while continuing to deliver the clinical benefits of the implant-free arstaotomy procedure.
May 18, 2011
This podcast explains how syngo Dynamics can be used to integrate cardiac imaging picture archiving and communication ...
May 16, 2011Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023News
May 16, 2011 - Cordis announces the launch in Europe of Radial Solutions, a complete portfolio for transradial interventions. New to the portfolio is the Cordis Radialsource Transradial Access Kit. Radialsource Transradial Sheaths are designed to provide physicians with atraumatic and smooth access to the radial artery during diagnostic and interventional procedures.
May 16, 2011
News
May 16, 2011— GE Healthcare today received the Price Performance Value Leadership Award in PET (Positron Emission Tomography) for North America 2011 from global research organization Frost & Sullivan.
May 16, 2011
News
May 16, 2011 - The German Supreme Court (BGH) declared a structural heart occluder patent case to be invalid. In the ruling by the BGH, the court does not see any basis for AGA/St. Jude's claim that the Occlutech atrial septal defects and patent foramen ovale (ASD and PFO) occluders violate any patent brought forward in the litigation and declares earlier German ruling to the contrary invalid.
May 16, 2011© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now